Meningococcal conjugate vaccines: new opportunities and new challenges
- 1 August 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 354 (9179), 615-616
- https://doi.org/10.1016/s0140-6736(99)00252-4
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Bacterial Vaccines and Serotype Replacement: Lessons fromHaemophilus influenzaeand Prospects forStreptococcus pneumoniaeEmerging Infectious Diseases, 1999
- The effects of host heterogeneity on pathogen population structurePhilosophical Transactions Of The Royal Society B-Biological Sciences, 1999
- Uncloaking the meningococcus: dynamics of carriage and diseaseThe Lancet, 1999
- Serogroup Y meningococcal disease in Chicago, 1991-1997.JAMA, 1998
- Induction of Immunologic Memory by Conjugated vs Plain Meningococcal C Polysaccharide Vaccine in ToddlersJAMA, 1998
- Enhanced surveillance of invasive Haemophilus influenzae disease in England, 1990 to 1996: impact of conjugate vaccinesThe Pediatric Infectious Disease Journal, 1998
- Multilocus sequence typing: A portable approach to the identification of clones within populations of pathogenic microorganismsProceedings of the National Academy of Sciences, 1998
- Molecular Epidemiology of Sporadic (Endemic) Serogroup C Meningococcal DiseaseThe Journal of Infectious Diseases, 1997
- Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian childrenThe Pediatric Infectious Disease Journal, 1993
- Antigenic and Epidemiologic Properties of the ET-37 Complex of Neisseria meningitidisThe Journal of Infectious Diseases, 1993